Skip to Main content Skip to Navigation
Patents

Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization

Abstract : A new process for the enantiomeric separation of racemic 3,6-dihydro-1,3,5-triazine derivatives for the treatment of disorders associated with insulin-resistance syndrome, by preferential crystallization.
Complete list of metadatas

https://hal-normandie-univ.archives-ouvertes.fr/hal-01949529
Contributor : Aurélien Lemercier <>
Submitted on : Monday, December 10, 2018 - 11:06:02 AM
Last modification on : Monday, December 2, 2019 - 2:44:06 PM

Identifiers

  • HAL Id : hal-01949529, version 1

Citation

Matthias Helmreich, Claus-Peter Niesert, Daniel Cravo, Gérard Coquerel, Guillaume Levilain, et al.. Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization. France, Patent n° : EP2411375A1. 2009. ⟨hal-01949529⟩

Share

Metrics

Record views

12